fbpx

CASE ENTRY

Dolin v. GlaxoSmithKline LLC

Man takes generic antidepressant, commits suicide. His widow sues not the manufacturer of the generic drug, but the manufacturer of the brand-name version, Paxil, which was responsible for the warning label. Widow: The harm wasn’t taking the drug; the harm was that the warning label failed to warn the drug was linked to suicide in adults. Drugmaker: We tried to include that on the label, but the FDA wouldn’t let us. Seventh Circuit: Case dismissed.


Tags: 2018, FDA, Preemption, Seventh Circuit

Sign up to receive IJ's biweekly digital magazine, Liberty & Law along with breaking updates about our fight to protect the rights of all Americans.

JOIN THE FIGHT!